712 related articles for article (PubMed ID: 22499613)
41. Human biodistribution and dosimetry of the PET radioligand [¹¹C]flumazenil (FMZ).
Laymon CM; Narendran R; Mason NS; Carney JP; Lopresti BJ; Mathis CA; Mountz JM; Sashin D; Frankle WG
Mol Imaging Biol; 2012 Feb; 14(1):115-22. PubMed ID: 21365327
[TBL] [Abstract][Full Text] [Related]
42.
Nishii R; Higashi T; Kagawa S; Okuyama C; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 May; 32(4):256-263. PubMed ID: 29453681
[TBL] [Abstract][Full Text] [Related]
43. Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.
O'Keefe GJ; Saunder TH; Ng S; Ackerman U; Tochon-Danguy HJ; Chan JG; Gong S; Dyrks T; Lindemann S; Holl G; Dinkelborg L; Villemagne V; Rowe CC
J Nucl Med; 2009 Feb; 50(2):309-15. PubMed ID: 19164222
[TBL] [Abstract][Full Text] [Related]
44. Radiation Dosimetry and Biodistribution of
Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
[TBL] [Abstract][Full Text] [Related]
45. Internal dose assessment of (-)-18F-flubatine, comparing animal model datasets of mice and piglets with first-in-human results.
Sattler B; Kranz M; Starke A; Wilke S; Donat CK; Deuther-Conrad W; Patt M; Schildan A; Patt J; Smits R; Hoepping A; Schoenknecht P; Steinbach J; Brust P; Sabri O
J Nucl Med; 2014 Nov; 55(11):1885-92. PubMed ID: 25286922
[TBL] [Abstract][Full Text] [Related]
46. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
[TBL] [Abstract][Full Text] [Related]
47. Whole-body distribution and radiation dosimetry of (68)Ga-NOTA-RGD, a positron emission tomography agent for angiogenesis imaging.
Kim JH; Lee JS; Kang KW; Lee HY; Han SW; Kim TY; Lee YS; Jeong JM; Lee DS
Cancer Biother Radiopharm; 2012 Feb; 27(1):65-71. PubMed ID: 22149685
[TBL] [Abstract][Full Text] [Related]
48. Report on the PET/CT Image-Based Radiation Dosimetry of [
McCall KC; Liu M; Cheng SC; Abbott A; Dubey S; Young D; Johnston M; Van den Abbeele AD; Overmoyer B; Jacene H
J Nucl Med Technol; 2023 Sep; 51(3):204-210. PubMed ID: 37316304
[TBL] [Abstract][Full Text] [Related]
49. Biodistribution, Tumor Detection, and Radiation Dosimetry of
Young CR; Adler S; Eary JF; Lindenberg ML; Jacobs PM; Collins J; Kummar S; Kurdziel KA; Choyke PL; Mena E
J Nucl Med; 2019 Apr; 60(4):492-496. PubMed ID: 30389817
[TBL] [Abstract][Full Text] [Related]
50. Human biodistribution and radiation dosimetry for the tau tracer [
Lin KJ; Huang SY; Huang KL; Huang CC; Hsiao IT
EJNMMI Radiopharm Chem; 2024 Apr; 9(1):27. PubMed ID: 38563872
[TBL] [Abstract][Full Text] [Related]
51. (18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases.
Yu C; Pan D; Mi B; Xu Y; Lang L; Niu G; Yang M; Wan W; Chen X
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2021-8. PubMed ID: 26121930
[TBL] [Abstract][Full Text] [Related]
52. The clinical safety, biodistribution and internal radiation dosimetry of flutemetamol (¹⁸F) injection in healthy Japanese adult volunteers.
Senda M; Brooks DJ; Farrar G; Somer EJ; Paterson CL; Sasaki M; McParland BJ
Ann Nucl Med; 2015 Aug; 29(7):627-35. PubMed ID: 26044876
[TBL] [Abstract][Full Text] [Related]
53. Radiation dosimetry estimates of (18)F-alfatide II based on whole-body PET imaging of mice.
Wang SY; Bao X; Wang MW; Zhang YP; Zhang YJ; Zhang JP
Appl Radiat Isot; 2015 Nov; 105():1-5. PubMed ID: 26218449
[TBL] [Abstract][Full Text] [Related]
54. Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors.
Sandström M; Velikyan I; Garske-Román U; Sörensen J; Eriksson B; Granberg D; Lundqvist H; Sundin A; Lubberink M
J Nucl Med; 2013 Oct; 54(10):1755-9. PubMed ID: 23929824
[TBL] [Abstract][Full Text] [Related]
55. A Microdose PET Study of the Safety, Immunogenicity, Biodistribution, and Radiation Dosimetry of
Keat N; Kenny J; Chen K; Onega M; Garman N; Slack RJ; Parker CA; Lumbers RT; Hallett W; Saleem A; Passchier J; Lukey PT
J Nucl Med Technol; 2018 Jun; 46(2):136-143. PubMed ID: 29438002
[TBL] [Abstract][Full Text] [Related]
56. Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET/CT in healthy human volunteers.
Brody AL; Okita K; Shieh J; Liang L; Hubert R; Mamoun M; Farahi J; Mandelkern MA
Nucl Med Biol; 2014; 41(10):871-5. PubMed ID: 25156039
[TBL] [Abstract][Full Text] [Related]
57. Safety, Biodistribution, and Radiation Dosimetry of
Tolvanen T; Kalliokoski K; Malaspina S; Kuisma A; Lahdenpohja S; Postema EJ; Miller MP; Scheinin M
J Nucl Med; 2021 May; 62(5):679-684. PubMed ID: 33067338
[TBL] [Abstract][Full Text] [Related]
58. Biodistribution and Internal Radiation Dosimetry of
Song YS; Kim JH; Lee BC; Jung JH; Park HS; Kim SE
Cancer Biother Radiopharm; 2018 Nov; 33(9):396-402. PubMed ID: 30133309
[TBL] [Abstract][Full Text] [Related]
59. Clinical translation of
Dubash SR; Keat N; Kozlowski K; Barnes C; Allott L; Brickute D; Hill S; Huiban M; Barwick TD; Kenny L; Aboagye EO
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2549-2561. PubMed ID: 32123971
[TBL] [Abstract][Full Text] [Related]
60. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
